Clotting Chronicles: Coagulation Pediatrics

Dr. Anthony Chan is a pediatric hematologist/oncologist at Hamilton Health Sciences and a Professor of Pediatrics at McMaster University. He currently holds the McMaster Children’s Hospital/Hamilton Health Sciences Foundation Chair in Pediatric Thrombosis and Hemostasis (third term). He is the Director of the Pediatric Thrombosis Clinic and Hemophilia Clinic at McMaster Children’s Hospital and is a clinical scientist with the Thrombosis & Atherosclerosis Research Institute (TaARI) and David Braley Cardiac, Vascular and Stroke Research Institute (DBCVSRI).

Dr. Chan is considered to be one of the leading experts in the field of pediatric thrombosis and stroke. He is involved in designing clinical studies in pediatric thrombosis, pediatric stroke and hemophilia from a hematology perspective.

His research focus is on the development, characterization and application of a covalent antithrombin-heparin complex (ATH), a potent anticoagulant that can be used as a systemic drug or can be grafted onto the surface of medical devices to render them non-thrombogenic.

Commonly Encountered CBC Abnormalities: What to do, when to refer.

Dr. Aryand Barghi is an  assistant professor of medicine at Western University.

Dr. Barghi's research interests include general benign hematology, lymphoma and myeloma.

Advancements in Blood Transfusion: Update Your Blood Consent Discussions

Dr. Solh works as a Transfusion Medicine Specialist and a Hematologist focusing on patients with special blood transfusion needs. As the Division Head of Transfusion Medicine, his focus is on blood transfusion quality and safety, implementation of appropriate transfusion orders for all blood products (red cells, platelets, plasma, plasma protein products such as IVIG), massive transfusion protocols, and immunohematology testing. 

Dr. Ziad Solh focuses on implementing novel transfusion medicine research findings into daily clinical practice (Knowledge Translation) at London Health Sciences Centre and St. Joseph's Health Care London. As a clinical hematologist, he is the medical director of the Adult Hemoglobinopathy Program where he work with a multidisciplinary team to optimize the care of patients with sickle cell disease and thalassemia in the region.

Dr. Solh has an interest in sickle cell disease and thalassemia quality improvement research, and is the local Principal Investigator on trials using novel drug therapies for these rare inherited blood disorders.

How Long to Thin?

Dr. Lazo-Langner is the  acting Chair/Chief Division of Hematology at McMaster University, and and associate professor of Medicine, Oncology, and Epidemiology and Biostatistics at Western University.
He is a faculty Scholar at the Institute For Clinical Evaluative Sciences at Western University, and an associate Scientist at the  Lawson Health Research Institute.

Dr. Lazo-Langner's areas of expertise are venous thromboembolic disease, thrombosis, systematic reviews and meta-analysis, and epidemiological methods. His research interests are focused on health outcomes and effectiveness research, population based studies in venous thromboembolism, determinants of thromboembolic diseases, clinical trials in thromboembolic disease, risk-benefit analysis and decision making. His secondary research interests include clinical and observational studies involving hematological malignancies.  

Navigating Hematologic Emergencies: A Focus on severe thrombocytopenia and anemia

Dr. Hsia is an associate professor of medicine at Western University, and is an  associate Medical Director of Transfusion Medicine Laboratories at  London Health Sciences Centre.

Dr. Hsia's research interests are in general Hematology and Transfusion Medicine.